Product :
BAY 63-2521 Riociguat
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
| Product name：BAY 63-2521 Riociguat |
Purity：98% min |
| CAS NO：625115-55-1 |
Solubility：DMSO : ≥ 50 mg/mL (118.37 mM) |
| Molecular Formula：C20H19FN8O2 |
Package：Package according to customer requirements |
| Molecular Weight：422.416 |
Storage：Store at -20℃ |
Remarks
Riociguat, also known as BAY 63-2521, is a novel drug that is currently in clinical development by Bayer. It is a stimulator of soluble guanylate cyclase (sGC). At the moment Phase III clinical trials investigate the use of riociguat as a new approach to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drug of a novel class of sGC stimulators.